Aura DR 43C-AG flat panel detector

K151014 · Abyzr Co., Ltd. · MQB · Jul 13, 2015 · Radiology

Device Facts

• Record ID: K151014
• Device Name: Aura DR 43C-AG flat panel detector
• Applicant: Abyzr Co., Ltd.
• Product Code: MQB · Radiology
• Decision Date: Jul 13, 2015
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 892.1680
• Device Class: Class 2

Intended Use

The AURA DR 43C-AG detector is indicated for digital imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic system in all general-purpose diagnostic procedures. It is not to be used for mammography.

Device Story

AURA DR 43C-AG is a digital X-ray flat panel detector (43cm x 43cm) for general radiography. Device intercepts X-ray photons via Gadox:Tb scintillator; converts to visible light; illuminates amorphous silicon (a-SI) TFT array to generate electrical signals. Signals converted to digital values; transferred via tethered Giga-bit Ethernet to an integrated operating PC and X-ray generator. System displays images on monitor for diagnostic review by physicians/healthcare professionals. Enables efficient image management and network sharing. Replaces film/screen-based systems. Used in clinical settings (upright stands, tables, universal stands).

Clinical Evidence

No clinical data. Substantial equivalence supported by bench testing, including electrical safety (IEC 60601-1), EMC (IEC 60601-1-2), and performance metrics (DQE, MTF, NPS). Results demonstrate equivalent or superior resolution and signal utilization efficiency compared to the predicate device.

Technological Characteristics

Amorphous Silicon (a-SI) TFT flat panel detector; Gadox:Tb scintillator; 17x17 inch imaging area; 3072x3072 pixel matrix; 140 μm pixel pitch; 16-bit A/D conversion; Giga-bit Ethernet connectivity; 460x460x15 mm form factor. Complies with IEC 60601-1 and IEC 60601-1-2.

Indications for Use

Indicated for digital radiographic imaging of human anatomy in general-purpose diagnostic procedures. Not for mammography.

Regulatory Classification

Identification

A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Special Controls

*Classification.* Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

• LLX240AB01 (K102587)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an image of three stylized human profiles facing to the right. The profiles are stacked on top of each other, with the top profile being the largest and the bottom profile being the smallest.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 13, 2015

AbyzR Co., Ltd. % Mr. David Kim Medical Device Regulatory Affairs Mtech Group 8310 Buffalo Speedway HOUSTON TX 77025

Re: K151014

Trade/Device Name: AURA DR 43C-AG Digital Flat Panel X-ray Detector Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary x-ray system Regulatory Class: II Product Code: MQB Dated: June 17, 2015 Received: June 18, 2015

Dear Mr. Kim:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

For

Robert Ochs, Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K151014

Device Name AURA DR 43C-AG Digital Flat Panel X-ray Detector

#### Indications for Use (Describe)

The AURA DR 43C-AG detector is indicated for digital imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic system in all general-purpose diagnostic procedures. It is not to be used for mammography.

| Type of Use (Select one or both, as applicable) | |
|----------------------------------------------------------------------------|--|
| <div> <span>☑</span> Prescription Use (Part 21 CFR 801 Subpart D) </div> | |
| <div> <span>☐</span> Over-The-Counter Use (21 CFR 801 Subpart C) </div> | |

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# SECTION 07

# 510(k) SUMMARY

{4}------------------------------------------------

## 1. Traditional 510(k) SUMMARY

This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of SMDA 1990 and 21 CFR Part 807.92.

Date 510K summary prepared : June 17, 2015

Submitter's Name, address, telephone number, a contact person:

| Submitter's Name : | AbyzR Co., Ltd. |
|-------------------------|----------------------------------------------------|
| Submitter's Address: | #63-27, Geumgok-ro, Dongtan-myeon, Hwaseong-si, |
| | Gyeonggi-do, 445-811, Korea |
| Submitter's Telephone: | Tel:+ 82-70-8680-4100 |
| Contact person: | Mr. John Lim / Sr. Manager ([e-mail]) |
| Official Correspondent: | Dave Kim, MBA |
| Address: | 8310 Buffalo Speedway, Houston, TX 77025 |
| Telephone: | [phone] |
| Fax: | [phone] |
| Email: | [e-mail] |

Name of the device, including the trade or proprietary name if applicable, the common or usual name and the classification name, if known:

| Trade/proprietary name: | AURA DR 43C-AG |
|-------------------------|-------------------------------------------------------|
| Regulation Name: | Stationary X-ray System |
| Regulation Number: | 21 CFR 892.1680 |
| Regulatory Class: | II |
| Product Code: | MQB |
| Predicate Device | |
| Manufacturer | Samsung Mobile Display Co., Ltd |
| Device | LLX240AB01 |
| Regulation Name | Stationary X-ray System |
| Regulation Number | 21 CFR 892.1680 |
| Product Code | MQB |
| 510(k) Number | K102587 |
| Decision Date | DEC 1, 2010 (Regulation Name Revised on Aug 23, 2013) |

#### 2. Device Description

AURA DR 43C-AG is a digital X-ray flat panel detector which has 43cm x 43cm imaging area and communicates with a wired communication feature, Giga-bit Ethernet communication method through connecting a tether cable. The device intercepts x-ray photons and the scintillator (Gadox:Tb) and emits visible spectrum photons that illuminate an array of photo (a-SI) detector that creates electrical signals. After the electrical signals are generated, it is converted to digital values, and the images will be displayed on the monitor. This device should be integrated with an operating PC and an X-Ray generator. It can digitalize x-ray images and transfer them for radiography diagnostics. Advanced digital image processing allows considerably efficient diagnosis, all kinds of information management, and sharing of image

{5}------------------------------------------------

information on network.

### 3. Indications for Use

The AURA DR 43C-AG detector is indicated for digital imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic system in all generalpurpose diagnostic procedures. It is not to be used for mammography.

#### 4. Summary of Design Control Risk management

The AURA DR 43C-AG detector has been developed to meet the critical functional requirements and international safety standards. The risks and the hazardous impact of the device design were analyzed with FMEA method. The specific risk control and protective measures to mitigate the risks from the device design and production phase were reviewed and implemented in the new product design phase. The overall assessment concluded that all risks and hazardous conditions identified arising from the design and production were successfully mitigated and accepted.

# 5. Summary of the technological characteristics of the device compared to the predicate device:

The AURA DR 43C-AG detector described in this 510(k) has similar indications for use and technical characteristics as the predicate device, LLX240AB01 digital flat panel X-ray detector manufactured by Samsung Mobile Display Co., Ltd.

### 6. Substantial Equivalence

The AURA DR 43C-AG detector and components conform to the FDA recognized standards as like the predicate device. Based on the recognized standard conformity evidences related to electro-, mechanical-, software-,nonclinical-, and risk management, it is confirmed that AURA DR 43C-AG is substantially equivalent to the predicate device.

| Characteristic | Proposed<br>AbyzR<br>AURA DR 43C-AG | Proposed<br>Samsung Mobile Display<br>LLX240AB01 | Remark |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| 510(k) number | - | K102587 | |
| Intended Use | The AURA DR 43C-AG detector is<br>indicated for digital imaging<br>solution designed for general<br>radiographic system for human<br>anatomy. It is intended to replace<br>film or screen based radiographic<br>system in all general-purpose<br>diagnostic procedures. It is not to<br>be used for mammography. | LLX240AB01 Digital Flat Panel X-Ray<br>Detector is indicated for digital<br>imaging solution designed for<br>providing general radiographic<br>diagnosis of human anatomy<br>targeting both adult and children. It<br>is intended to replace film based<br>radiographic diagnostic systems and<br>provide a case diagnosis and<br>treatment planning for physicians<br>and other health care professionals.<br>Not to be used for mammography. | Same |

{6}------------------------------------------------

| Detector Type | Amorphous Silicon, TFT | Amorphous Silicon, TFT | Same |
|----------------|-------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|------------|
| scintillator | Gadox:Tb | Gadox:Tb | Same |
| Imaging Area | 17 x 17 inches | 17 x 17 inches | Same |
| Pixel matrix | 3072 x 3072 (9.4 million) | 3072 x 3072 (9.4 million) | Same |
| Pixel pitch | 140 μm | 143 μm | Similarity |
| Resolution | 3.5 lp/mm | 3.5 lp/mm | Same |
| A/D conversion | 16 bit | 14 bit | Similarity |
| Grayscale | 16384 (14bit) | 16384 (14bit) | Same |
| Data output | RAW<br>*The RAW files are convertible<br>into DICOM 3.0 by console S/W | RAW<br>*The RAW files are convertible into<br>DICOM 3.0 by console S/W | Same |
| Dimensions | 460 x 460 x 15 mm | 500 x 496.6 x 45 mm | Similarity |
| Application | General Radiology system<br>Available with upright stand,<br>table, universal stand | General Radiology system<br>Available with upright stand, table,<br>universal stand | Same |
| picture | Image: detector | Image: detector | Similarity |

When compared to the predicate device (K102587), the AURA DR43C-AG presented in this submission has very similar characteristics as the predicate device in terms of:

- Intended Use
- Technological characteristics
- · Operating principle
- · Design features
- Performance
- · Communication Method

There are no significant difference between the AURA DR43C-AG and the predicate device that would adversely affect the use of the product. It is substantially equivalent to these devices in design, function, materials, operational principles and intended use.

### 7. Performance Testing/Data

To minimize electrical and mechanical hazards, AbyzR CO., LTD. adheres to recognized and established industry practice, and all equipment complies with the relevant FDA and international standards. For example, electrical, mechanical safety and performance testing according to standard IEC

{7}------------------------------------------------

60601-1: 2005 + CORR. 1 (2006) + CORR. 2 (2007) + AM1 (2012) was performed and EMC testing was conducted in accordance with standard IEC 60601-1-2: 2007. EN 60601-1-2:2007

Through verification and validation activities, the safety and effectiveness of AURA DR 43C-AG is verified and validated. Engineering testing and standards compliance testing were successfully conducted and did not raise any new safety questions or concerns or identify new risks.

The instructions for use are included within the device labeling, and the information provided will enable the user to operate the device in a safe and effective manner.

#### 8. Description of non-clinical tests.

#### - Non-clinical study

The non-clinical performance testing constrains that the main physical values for comparison of X-ray devices like DQE, MTF NPS are basically equivalent or performed better compared to the predicate device LLX240AB01 (K102587). The results show that AURA DR 43C-AG offers better resolution performance than LLX240AB01 at 0 ~ 3.5lp/mm spatial frequencies. Moreover, the ability of AURA DR 43C-AG to utilize the input image signal is more efficient than LLX240AB01 at same patient exposure.

#### -Electrical safety and EMC

AURA DR43C-AG has been tested for electrical safety standard IEC 60601-1: 2005 + CORR. 1 (2006) + CORR. 2 *2007) + AM1 (2012) and electromagnetic compatibility IEC 60601-1: 2005 + CORR. 1 (2006) + CORR. 2 (2007) + AM1 (2012).

The software validation and verification testing was also performed. The results of nonclinical testing indicate that the AURA DR 43C-AG detector is as safe and effective as the predicate device.

Compliance evidences were submitted for the following standards:

- IEC 60601-1: Test Report issued by 3rd party testing lab A
- IEC 60601-1-2: Test Report issued by 3rd party testing lab A
- A ISO 14971: Risk management file

### 9. Clinical tests

Clinical testing is not necessary to support substantial equivalence of AURA DR 43C-AG with regard to LLX240AB01, the predicate device.

### 10. Conclusion as to Substantial Equivalence

The AURA DR43C-AG detector is substantially equivalent to the predicate device LLX240AB01 (K102587). Both subject and predicate devices are same or very similar in the intended use, the design principle, the performance and the applicable standards. Some characteristics, for example, their appearance, pitch and weight are different. However the compliance reports, performance demonstrations in this submission STED provide demonstration that these differences do not raise any new questions of safety and effectiveness. Therefore, AbyzR CO., LTD. concludes the AURA DR43C-AG digital flat panel detector is substantially equivalent with the predicate device LLX240AB01 (K102587) of Samsung Mobile Display Co., Ltd.